Cannabis
Hill Street Announces Closing First Tranche of Non-Brokered Private Placement
Hill Street Beverage Company Inc. (“Hill Street” or “Company“) (TSX-V: BEER) is pleased to announce that it has closed the first tranche of a $5 million non-brokered private placement that was announced May 28, 2019.
The Company has issued a total of 8,483,308 units (“Units“) at a price of $0.20 per Unit for aggregate gross proceeds of $1,696,661.51.
Each Unit is comprised of one (1) Hill Street Common Share and one-half of one (1/2) warrant (each whole warrant a “Warrant“), with each Warrant entitling the holder thereof to acquire one (1) Hill Street Common Share at a price of $0.40 per share for a period of two (2) years from the date of Closing.
All the securities will be subject to a four-month hold period from the date of closing. Hill Street intends to use the net proceeds for funding day-to-day operations and general working capital purposes.
In connection with the closing, the Company paid finders fees to James Eric Salter, in the amount of $37,450 together with 187,250 finder warrants, with each finder warrant entitling the holder to acquire 1 common share in the capital of the Company at a purchase price of $0.20 per share for a period of two years from the date of issuance.
SOURCE Hill Street Beverage Co.
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis1 day ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt24 hours ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace